Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials related to the research mission of the NIAID.
This program provides support for
hypothesis-driven, milestone-driven clinical trials.
Although clinical trials not considered high-risk may be proposed, this program encourages high-risk clinical studies.
High-risk does not imply human subject or patient risk, but rather defines a study that contains one or more of the following unique features:
involves non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication.
Mechanistic studies are also encouraged and can be proposed under this program.
This program provides support for
hypothesis-driven, milestone-driven clinical trials.
Although clinical trials not considered high-risk may be proposed, this program encourages high-risk clinical studies.
High-risk does not imply human subject or patient risk, but rather defines a study that contains one or more of the following unique features:
involves non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication.
Mechanistic studies are also encouraged and can be proposed under this program.
Related Programs
Allergy, Immunology and Transplantation Research
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $160,000,000
Office: National Institutes of Health
Estimated Funding: $160,000,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-21-082.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-21-082.html
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2021-01-14
Application Due Date:
Archive Date:
2024-02-18
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
